Big Pharma coalition will pool data on failed Alzheimer’s drugs

Johnson & Johnson, GlaxoSmithKline, AstraZeneca, Sanofi-Aventis and Abbott Labs are releasing results from 11 failed Alzheimer's programs with the hope that the information will help researchers better understand the disease. Alzheimer's is a difficult-to-treat condition and clinical successes are few and far between. More drugmakers, along with the National Institutes of Health, plan to join the coalition in the future. The project is backed by the FDA and Science Foundation...